Adaptive immunity to fungi

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 3, 2015, Pages

  Verma, Akash ^a   Wüthrich, Marcel ^b   Deepe, George ^a   Klein, Bruce ^b   Giri, Geet ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; DECTIN 2; MANNOSE RECEPTOR; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELLULAR IMMUNITY; DENDRITIC CELL; DIFFERENTIATION; FUNGUS IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INTESTINE; LUNG; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MYCOSIS; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SKIN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; FUNGUS; IMMUNOLOGY; INNATE IMMUNITY; MOUSE; MYCOSES; PATHOGENICITY; SIGNAL TRANSDUCTION;

FUNGI; MAMMALIA;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; FUNGI; HUMANS; IMMUNITY, INNATE; MICE; MONOCYTES; MYCOSES; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84923862356     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a019612     Document Type: Article

References (215)

1. Aguirre KM, Johnson LL. 1997. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect Immun 65: 525-530.
2. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
3. Allendoerfer R, Deepe GS Jr. 1997. Intrapulmonary response to Histoplasma capsulatum in g interferon knockout mice. Infect Immun 65: 2564-2569.
4. Allendoerfer R, Deepe GS Jr. 1998. Blockade ofendogenous TNF-a exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 160: 6072-6082.
5. Al-Saud BK, Al-Sum Z, Alassiri H, Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, Arnaout R, Alsmadi O, Borrero E, Abu-Staiteh A, et al. 2013. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol 33: 1325-1335.
6. Aytekin C, Dogu F, Tuygun N, Tanir G, Guloglu D, Boisson-Dupuis S, Bustamante J, Feinberg J, Casanova JL, Ikin-ciogullari A. 2011. Bacille Calmette-Guerin lymphadenitis and recurrent oral candidiasis in an infant with a new mutation leading to interleukin-12 receptor fS-1 deficiency. J Investig Allergol Clin Immunol 21: 401-404.
7. Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS. 2005. Frequency of interleukin-4 (IL-4)-589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 40: 1258-1262.
8. Backer R, van Leeuwen F, Kraal G, denHaan JM. 2008. CD8dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. Eur J Immunol 38: 370-380.
9. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
10. Beaman L. 1987. Fungicidal activation of murine macrophages by recombinant g interferon. Infect Immun 55: 2951-2955.
11. Beaty SR, Rose CE Jr, Sung SS. 2007. Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation. J Immunol 178: 1882-1895.
12. Bellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G, Mambula SS, Vecchi A, Mantovani A, Levitz SM, Romani L. 2004. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172: 3059-3069.
13. Biondo C, Midiri A, Messina L, Tomasello F, Garufi G, Catania MR, Bombaci M, Beninati C, Teti G, Mancuso G. 2005. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur JImmunol 35: 870-878.
14. Biondo C, Signorino G, Costa A, Midiri A, Gerace E, Galbo R, Bellantoni A, Malara A, Beninati C, Teti G, et al. 2011. Recognition ofyeast nucleic acids triggers a host-protective type I interferon response. Eur J Immunol 41: 19691979.
15. Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, et al. 2008. Toll-like receptor 4 polymorphisms and aspergil-losis in stem-cell transplantation. N Engl J Med 359: 1766-1777.
16. Bourgeois C, Majer O, Frohner IE, Lesiak-Markowicz I, Hildering KS, Glaser W, Stockinger S, Decker T, Akira S, Muller M, et al. 2011. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-fS signaling. J Immunol 186: 3104-3112.
17. Bozza S, Zelante T, Moretti S, Bonifazi P, DeLuca A, D'An-gelo C, Giovannini G, Garlanda C, Boon L, Bistoni F, et al. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 180: 4022-4031.
18. Brena S, Cabezas-Olcoz J, Moragues MD, Fernandezde Lar-rinoa I, Dominguez A, Quindos G, Ponton J. 2011. Fun-gicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans. Antimicrob Agents Chemother 55: 3156-3163.
19. Bretz C, Gersuk G, Knoblaugh S, Chaudhary N, Randolph-Habecker J, Hackman RC, Staab J, Marr KA. 2008. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect Immun 76: 952-958.
20. Brown GD. 2011. Innate antifungal immunity: The key role of phagocytes. Annu Rev Immunol 29: 1-21.
21. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: Human fungal infections. Sci Transl Med 4: 165-113.
22. Brummer E, Stevens DA. 1995. Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macro-phages for Histoplasma capsulatum. Clin Exp Immunol 102: 65-70.
23. Calich VL, Pina A, Felonato M, Bernardino S, Costa TA, Loures FV. 2008. Toll-like receptors and fungalinfections: The role of TLR2, TLR4 and MyD88 in paracoccidioido-mycosis. FEMS Immunol Med Microbiol 53: 1-7.
24. Calvi SA, Peracoli MT, Mendes RP, Marcondes-Machado J, Fecchio D, Marques SA, Soares AM. 2003. Effect ofcyto-kines on the in vitro fungicidal activity of monocytes from paracoccidioidomycosis patients. Microbes Infect 5: 107-113.
25. Carrow EW, Hector RF, Domer JE. 1984. Immunodeficient CBA/N mice respond effectively to Candida albicans. Clin Immunol Immunopathol 33: 371-380.
26. Carvalho A, De Luca A, Bozza S, Cunha C, D'Angelo C, Moretti S, Perruccio K, Iannitti RG, Fallarino F, Pierini A, et al. 2012. TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 119: 967-977.
27. Casadevall A, Pirofski LA. 2012. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 11: 447-456.
28. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23: 1034-1038.
29. Chai LY, Kullberg BJ, Vonk AG, Warris A, Cambi A, Latge JP, Joosten LA, van der Meer JW, Netea MG. 2009. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 77: 2184-2192.
30. Chen K, Xu W, Wilson M, He B, Miller NW, Bengten E, Edholm ES, Santini PA, Rath P, Chiu A, et al. 2009. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol 10: 889-898.
31. Cheng SC, van de Veerdonk F, Smeekens S, Joosten LA, van der Meer JW, Kullberg BJ, Netea MG. 2010. Candida albicans dampens host defense bydownregulating IL-17 production. JImmunol 185: 2450-2457.
32. Chiarella AP, Arruda C, Pina A, Costa TA, Ferreira RC, Ca-lich VL. 2007. The relative importance of CD4+ and CD8+T cells in immunity to pulmonary paracoccidioidomycosis. Microbes Infect 9: 1078-1088.
33. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
34. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL. 2011. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 4: 448-455.
35. Davis MJ, Tsang TM, Qiu Y, Dayrit JK, Freij JB, Huffnagle GB, Olszewski MA. 2013. Macrophage M1/M2 polarization dynamicallyadapts to changes in cytokine microen-vironments in Cryptococcus neoformans infection. MBio 4: e00264-00213.
36. Deepe GS Jr, Gibbons RS. 2008. TNF-a antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmo-sis. J Immunol 180: 1088-1097.
37. Deepe GS Jr, Gibbons RS. 2009. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis 200: 142-151.
38. Deepe GS Jr, Gibbons R, Woodward E. 1999. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. JImmunol 163: 4985-4993.
39. de Gorgolas M, Erice A, Gil A, Gutierrez J, Rivas P, Her-nando C, Rodriguez MC. 2005. Cryptococcal meningitis in apatient with X-linked hyper-IgM1 syndrome. ScandJ Infect Dis 37: 526-528.
40. del Rio ML, Rodriguez-Barbosa JI, Kremmer E, Forster R. 2007. CD1032 and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol 178: 6861-6866.
41. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F, et al. 2010. IL-22 defines a novel immune pathway of anti-fungal resistance. Mucosal Immunol 3: 361-373.
42. den Haan JM, Lehar SM, Bevan MJ. 2000. CD8+ but not CD82 dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192: 1685-1696.
43. Desch AN, Randolph GJ, Murphy K, Gautier EL, Kedl RM, Lahoud MH, Caminschi I, Shortman K, Henson PM, Jakubzick CV 2011. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 208: 1789-1797.
44. Devi SJ. 1996. Preclinical efficacy of a glucuronoxylo-mannan-tetanus toxoid conjugate vaccine of Cryptococ-cus neoformans in a murine model. Vaccine 14: 841-844.
45. Diamond RD, May JE, Kane MA, Frank MM, Bennett JE. 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neofor-mans infection. JImmunol 112: 2260-2270.
46. Dominguez PM, Ardavin C. 2010. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 234: 90-104.
47. Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. 2011. Two cases illustrating successful adjunctive inter-feron-g immunotherapy in refractory disseminated coccidioidomycosis. J Infect 63: 223-228.
48. Ersland K, Wuthrich M, Klein BS. 2010. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation ofvaccine immunity to fungi. Cell Host Microbe 7: 474-487.
49. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, et al. 2011. IL-22 and TNF-a represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur JImmunol 41: 18941901.
50. Feldmesser M, Mednick A, Casadevall A. 2002. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cyto-kine and leukocyte responses. Infect Immun 70: 1571-1580.
51. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, et al. 2009. Human Dectin-1 deficiency and mucocutaneous fungal infections. NEngl J Med 361: 1760-1767.
52. Fleuridor R, Lees A, Pirofski L. 2001. A cryptococcal capsu-lar polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol 166: 1087-1096.
53. Geijtenbeek TB, Gringhuis SI. 2009. Signalling through C-type lectin receptors: Shaping immune responses. Nat Rev Immunol 9: 465-479.
54. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
55. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J, Ochando J, Kissenpfennig A, Malissen B, Grisotto M, et al. 2007. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 204: 3133-3146.
56. Goodman WA, Cooper KD, McCormick TS. 2012. Regulation generation: The suppressive functions of human regulatory T cells. Crit Rev Immunol 32: 65-79.
57. Goren MB. 1967. Experimental murine cryptococcosis: Effect of hyperimmunization to capsular polysaccharide. J Immunol 98: 914-922.
58. Graham LM, Brown GD. 2009. The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine 48: 148-155.
59. Grimbacher B, Holland SM, Puck JM. 2005. Hyper-IgE syndromes. Immunol Rev 203: 244-250.
60. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, Geijtenbeek TB. 2009. Dectin-1 directs T helper cell differentiation by controlling nonca-nonical NF-kB activation through Raf-1 and Syk. Nat Immunol 10: 203-213.
61. Gringhuis SI, Wevers BA, Kaptein TM, van Capel TM, Theelen B, Boekhout T, de Jong EC, Geijtenbeek TB. 2011. Selective C-Rel activation via Malt1 controls anti-fungal TH-17 immunity by Dectin-1 and Dectin-2. PLoS Pathog 7: e1001259.
62. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, et al. 2009. Syk kinase signaling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436.
63. Gupta S, Ellis M, Cesario T, Ruhling M, Vayuvegula B. 1987. Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions. Am J Med 82: 129-131.
64. Han Y, Ulrich MA, Cutler JE. 1999. Candida albicans man-nan extract-protein conjugates induce a protective immune response against experimental candidiasis. JInfect Dis 179: 1477-1484.
65. Han Y, Kozel TR, Zhang MX, MacGill RS, Carroll MC, Cutler JE. 2001. Complement is essential for protection byan IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. JImmunol 167: 1550-1557.
66. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B, Devilard E, Viret C, Azukizawa H, Kis-senpfennig A, et al. 2010. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207: 189-206.
67. Hernandez-Santos N, Gaffen SL. 2012. Th17 cells in immu-nityto Candida albicans. Cell HostMicrobe 11: 425-435.
68. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487-497.
69. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, Lukacs NW. 2000. Chronic airway hyperreactivity, goblet cell hyperplasia, and peri-bronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156: 723-732.
70. Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, Pamer EG. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific βglu-can display. PLoS Pathog 1: e30.
71. Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, Pamer EG. 2009. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6: 470-481.
72. Hsieh SH, Lin JS, Huang JH, Wu SY, Chu CL, Kung JT, Wu-Hsieh BA. 2011. Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8+ T cells to protect against histoplasmosis. InfectImmun 79: 4493-4502.
73. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, Kunkel SL, Strieter RM. 1996. Afferent phase production of TNF-a is required for the development ofprotective T cellimmunityto Cryptococ-cus neoformans. JImmunol 157: 4529-4536.
74. Hurd RC, Drake CH. 1953. Candida albicans infections in actively and passively immunized animals. Mycopathol Mycol Appl 6: 290-297.
75. Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. 2009. Antibody to Langerin/CD207 localizes large numbers of CD8a+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci 106: 1524-1529.
76. Igyarto BZ, Haley K, Ortner D, Bobr A, Gerami-Nejad M, Edelson BT, Zurawski SM, Malissen B, Zurawski G, Ber-man J, et al. 2011. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity35: 260-272.
77. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, et al. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336: 1314-1317.
78. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. 2009. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, byC-type lectin Mincle. JExpMed 206: 2879-2888.
79. Ishikawa T, Itoh F, Yoshida S, Saijo S, Matsuzawa T, Gonoi T, Saito T, Okawa Y, Shibata N, Miyamoto T, et al. 2013. Identification of distinct ligands for the C-type lectin receptors Mincle and Dectin-2 in the pathogenic fungus Malassezia. Cell Host Microbe 13: 477-488.
80. Jahnsen FL, Strickland DH, Thomas JA, Tobagus IT, Napoli S, Zosky GR, Turner DJ, Sly PD, Stumbles PA, Holt PG. 2006. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. JImmunol 177: 5861-5867.
81. Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A, Schutz C, Bekker LG, Wood R, Harrison TS. 2012. Adjunctive interferon-g immunotherapy for the treatment ofHIV-associated cryptococcal meningitis: A randomized controlled trial. AIDS 26: 1105-1113.
82. Jirapongsananuruk O, Luangwedchakarn V, Niemela JE, Pa-charn P, Visitsunthorn N, Thepthai C, Vichyanond P, Piboonpocanun S, Fleisher TA. 2012. Cryptococcal osteomyelitis in a child with a novel compound mutation of the IL12RB1 gene. Asian Pac J Allergy Immunol 30: 7982.
83. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. 2010. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185: 5453-5462.
84. Kankkunen P, Teirila L, Rintahaka J, Alenius H, Wolff H, Matikainen S. 2010. (1,3)-β-glucans activate both Dec-tin-1 and NLRP3 inflammasome in human macrophages. J Immunol 184: 6335-6342.
85. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D, et al. 2012. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgRIIB and Dec-tin-1. Nat Med 18: 1401-1406.
86. Kasperkovitz PV, Cardenas ML, Vyas JM. 2010. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J Immunol 185:7614-7622.
87. Kekalainen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, Pontynen N, Talvensaari K, Perheentupa J, Miettinen A, Arstila TP. 2007. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidia-sis-ectodermal dystrophy. J Immunol 178: 1208-1215.
88. Kelleher P, Goodsall A, Mulgirigama A, Kunst H, Henderson DC, Wilson R, Newman-Taylor A, Levin M. 2006. Interferong therapy in two patients with progressive chronic pulmonary aspergillosis. Eur Respir J 27: 1307-1310.
89. Kerrigan AM, Brown GD. 2010. Syk-coupled C-type lectin receptors that mediate cellular activation via single tyro-sine based activation motifs. Immunol Rev 234: 335-352.
90. Kerrigan AM, Brown GD. 2011. Syk-coupled C-type lectins in immunity. Trends Immunol 32: 151-156.
91. Kerscher B, Willment JA, Brown GD. 2013. The Dectin-2 familyofC-type lectin-like receptors: An update. IntIm-munol 25: 271-277.
92. Kroetz DN, Deepe GS Jr. 2010. CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J Immunol 184: 5224-5231.
93. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, et al. 2007. Sykand CARD9-dependent coupling ofinnate immunityto the induction ofT helper cells that produce interleukin 17. Nat Immunol 8: 630638.
94. Levitz SM. 2009. Th17 cells bounce off the fungal wall. Cell Host Microbe 5: 311-313.
95. Li HS, Gelbard A, Martinez GJ, Esashi E, Zhang H, Nguyen-Jackson H, Liu YJ, Overwijk WW, Watowich SS. 2011. Cell-intrinsic role for IFN-a-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 118: 3879-3889.
96. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joan-nopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and co-operativelyenhance expression ofantimicrobial peptides. JExp Med 203: 2271-2279.
97. Lin JS, Yang CW, Wang DW, Wu-Hsieh BA. 2005a. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histo-plasma capsulatum. J Immunol 174: 6282-6291.
98. Lin JS, Yang CW, Wang DW, Wu-Hsieh BA. 2005b. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histo-plasma capsulatum. J Immunol 174: 6282-6291.
99. Lin L, Ibrahim AS, Baquir B, Avanesian V, Fu Y, Spellberg B. 2009. Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus. FEMS Immunol Med Microbiol 55: 293-295.
100. Lindell DM, Moore TA, McDonald RA, Toews GB, Huffnagle GB. 2005. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol 174: 7920-7928.
101. Lobato-Pascual A, Saether PC, Fossum S, Dissen E, Daws MR. 2013. Mincle, the receptor for mycobacterial cord factor, forms a functional receptor complex with MCL and FcsRI-g. Eur J Immunol 43: 3167-3174.
102. Loughman JA, Hunstad DA. 2012. Induction of indole-amine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. JInfect Dis 205: 1830-1839.
103. Loures FV, Pina A, Felonato M, Calich VL. 2009. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 183: 1279-1290.
104. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, Akira S, Wiegand M, Hochrein H, O'Keeffe M, et al. 2010. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32: 279-289.
105. Marquis M, Lewandowski D, Dugas V, Aumont F, Senechal S, Jolicoeur P, Hanna Z, de Repentigny L. 2006. CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Infect Immun 74: 2382-2391.
106. Marr KA, Datta K, Pirofski LA, Barnes R. 2012. Cryptococcus gattii infection in healthy hosts: A sentinel for subclinical immunodeficiency? Clin Infect Dis 54: 153-154.
107. Matheson DS, Green BJ. 1987. Defect in production ofB cell differentiation factor-like activity by mononuclear cells from a boy with hypogammaglobulinemia. J Immunol 138: 2469-2472.
108. Matthews R, Burnie J. 2001. Antifungal antibodies: A new approach to the treatment of systemic candidiasis. Curr Opin Investig Drugs 2: 472-476.
109. McAllister F, Steele C, Zheng M, Young E, Shellito JE, Marrero L, Kolls JK. 2004. T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol 172: 1132-1138.
110. McClelland EE, Nicola AM, Prados-Rosales R, Casadevall A. 2010. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin Invest 120: 1355-1361.
111. McGreal EP, Rosas M, Brown GD, Zamze S, Wong SY, Gordon S, Martinez-Pomares L, Taylor PR. 2006. The carbohydrate-recognition domain of Dectin-2 is a C-type lec-tin with specificity for high mannose. Glycobiology 16: 422-430.
112. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
113. Minegishi Y, Saito M. 2011. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome. Ann NY Acad Sci 1246: 34-40.
114. Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oya-mada A, Yamada H, Ono KI, Suyama M, Iwakura Y, et al. 2013. C-type lectin MCL is an FcRg-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity 38: 1050-1062.
115. Monga DP, Kumar R, Mohapatra LN, Malaviya AN. 1979. Experimental cryptococcosis in normal and B-cell-defi-cient mice. Infect Immun 26: 1-3.
116. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L. 2002. B7/CD28-dependent CD4+ CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. JImmunol 169: 6298-6308.
117. Montagnoli C, Fallarino F, Gaziano R, Bozza S, Bellocchio S, Zelante T, Kurup WP, Pitzurra L, Puccetti P, Romani L. 2006. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. JImmunol 176: 1712-1723.
118. Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade ME, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJ. 2005. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the β1 sub-unit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 41: e31-37.
119. Moreira AP, Cavassani KA, Massafera Tristao FS, Campanelli AP, Martinez R, Rossi MA, Silva JS. 2008. CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J Immunol 180: 3049-3056.
120. Muller U, Stenzel W, Piehler D, Grahnert A, Protschka M, Kohler G, Frey O, Held J, Richter T, Eschke M, et al. 2013. Abrogation of IL-4 receptor-a-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing Th2 response. Int Immunol 25: 459-470.
121. Nabavi N, Murphy JW. 1986. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans. Infect Immun 51: 556-562.
122. Nagai H, Guo J, Choi H, Kurup V. 1995. Interferon-g and tumor necrosis factora protect mice from invasive as-pergillosis. J Infect Dis 172: 1554-1560.
123. Nanjappa SG, Heninger E, Wuthrich M, Gasper DJ, Klein BS. 2012a. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog 8: e1002771.
124. Nanjappa SG, Heninger E, Wuthrich M, Sullivan T, Klein B. 2012b. Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice. JClin Invest 122: 987-999.
125. Nelson MP, Christmann BS, Werner JL, Metz AE, Trevor JL, Lowell CA, Steele C. 2011. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 186: 2372-2381.
126. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. 2004a. Toll-like receptor 2 suppresses immu-nityagainst Candida albicansthrough induction ofIL-10 and regulatory T cells. JImmunol 172: 3712-3718.
127. Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ. 2004b. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 23: 672-676.
128. Netea MG, Brown GD, Kullberg BJ, Gow NA. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
129. Neto R, Guimaraes MC, Moya MJ, Oliveira FR, Louzada PL Jr, Martinez R. 2000. Hypogammaglobulinemia as risk factor for Cryptococcus neoformans infection: Report of2 cases. Rev Soc Bras Med Trop 33: 603-608.
130. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS Jr, Casa-devall A. 2003. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112: 1164-1175.
131. Novak ML, Koh TJ. 2013. Macrophage phenotypes during tissue repair. J Leukoc Biol 93: 875-881.
132. Opata MM, Ye Z, Hollifield M, Garvy BA. 2013. B cell production of tumor necrosis factor in response to Pneumo-cystis murina infection in mice. Infect Immun 81: 42524260.
133. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. 2009. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol 183: 8044-8053.
134. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ. 2011. CD4+CD25+Foxp3+ regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity34: 422-434.
135. Perez-Nazario N, Rangel-Moreno J, O'Reilly MA, Pasparakis M, Gigliotti F, Wright TW. 2013. Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis. J Immunol 191: 4720-4730.
136. Pietrella D, Corbucci C, Perito S, Bistoni G, Vecchiarelli A. 2005. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect Immun 73: 820-827.
137. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, d'Enfert C, Vecchiarelli A. 2011. Th17 cells and ILin protective immunity to vaginal candidiasis. PLoS ONE 6: e22770.
138. Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, et al. 2012. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. JInfect Dis 205: 934-943.
139. Poeck H, Ruland J. 2010. SYK kinase signaling and the NLRP3 inflammasome in antifungal immunity. JMol Med 88: 745-752.
140. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:6568.
141. Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, Bromuro C, Proietti C, Bistoni F, Cassone A, Vecchiarelli A. 2007. An anti-βglucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofor-mans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 75: 5085-5094.
142. Ramirez-Ortiz ZG, Specht CA, Wang JP, Lee CK, Bartholomeu DC, Gazzinelli RT, Levitz SM. 2008. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 76: 2123-2129.
143. Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. 2011. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 9: 415-424.
144. Rapaka RR, Ricks DM, Alcorn JF, Chen K, Khader SA, Zheng M, Plevy S, Bengten E, Kolls JK. 2010. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 207: 2907-2919.
145. Rappleye CA, Eissenberg LG, Goldman WE. 2007. Histo-plasma capsulatum a-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc Natl Acad Sci 104: 1366-1370.
146. Rivera J, Zaragoza O, Casadevall A. 2005. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun 73: 1141-1150.
147. Rivera A, Hohl TM, Collins N, Leiner I, Gallegos A, Saijo S, Coward JW, Iwakura Y, Pamer EG. 2011. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med 208: 369-381.
148. Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E, Gross O, Verbeek JS, Ruland J, Tybulewicz V, Brown GD, et al. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206: 2037-2051.
149. Romani L. 2011. Immunity to fungal infections. Nat Rev Immunol 11: 275-288.
150. Rudner XL, Happel KI, Young EA, Shellito JE. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneu-mocystis carinii infection. Infect Immun 75: 3055-3061.
151. Said-Sadier N, Padilla E, Langsley G, Ojcius DM. 2010. Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS ONE 5: e10008.
152. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8:39-46.
153. aijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, et al. 2010. Dectin-2 recognition of a-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity32: 681-691.
154. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. 2006. Cytokine profiling of pulmonary aspergillosis. Int JImmunogenet 33: 297-302.
155. Sandini S, La Valle R, Deaglio S, Malavasi F, Cassone A, De Bernardis F. 2011. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anti-candidal vaccine. FEMS Immunol Med Microbiol 62: 215-224.
156. Sato K, Yang XL, Yudate T, Chung JS, Wu J, Luby-Phelps K, Kimberly RP, Underhill D, Cruz PD Jr, Ariizumi K. 2006. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor g chain to induce innate immune responses. JBiol Chem 281: 38854-38866.
157. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lo-pez-Ribot JL. 2008. Use ofa geneticallyengineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun 76: 97102.
158. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, et al. 2010. Cutting edge: Mincle is essential for recognition and adjuvanticity of the my-cobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184: 2756-2760.
159. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interfer-ong: An overview ofsignals, mechanisms and functions. JLeukocBiol 75: 163-189.
160. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-g and tumor necrosis factors. J Immunol 135: 2069-2073.
161. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S, Hieny S, Caspar P, Yama-saki S, et al. 2013. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activityofmyco-bacteria through Mincle/CARD9 signaling and the inflammasome. J Immunol 190: 5722-5730.
162. Shi L, Albuquerque PC, Lazar-Molnar E, Wang X, Santam-brogio L, Gacser A, Nosanchuk JD. 2008. A monoclonal antibody to Histoplasma capsulatum alters the intracellu-lar fate of the fungus in murine macrophages. Eukaryot Cell 7: 1109-1117.
163. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. 2001. Toll-like receptor 4 mediates intracellular signaling without TNF-a release in response to Cryptococcus neo-formans polysaccharide capsule. J Immunol 166: 4620-4626.
164. Smeekens SP, van de Veerdonk FL, van der Meer JW, Kull-berg BJ, Joosten LA, Netea MG. 2010. The Candida Th17 response is dependent on mannanand β-glucan-in-duced prostaglandin E2. Int Immunol 22: 889-895.
165. Snapper CM, Paul WE. 1987. Interferon-g and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
166. Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ran-ghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, et al. 2012. miR-511-3p modulates genetic programs of tumor-associated macrophages. CellRep 1: 141-154.
167. Steele C, Rapaka RR, Metz A, Pop SM, Williams DL, Gordon S, Kolls JK, Brown GD. 2005. The β-glucan receptor Dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 1: e42.
168. Steinman RM, Cohn ZA. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice: I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142-1162.
169. Subramanian Vignesh K, Landero Figueroa JA, Porollo A, Caruso JA, Deepe GS Jr. 2013. Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity 39: 697-710.
170. Sugar AM, Picard M, Wagner R, Kornfeld H. 1995. Interactions between human bronchoalveolar macrophages and Blastomyces dermatitidis conidia: Demonstration of fun-gicidal and fungistatic effects. J Infect Dis 171: 1559-1562.
171. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, Beaty SR. 2006. A major lung CD103 (aE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176: 2161-2172.
172. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116:485494.
173. Szymczak WA, Deepe GS Jr. 2009. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 183: 1964-1974.
174. Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA. 2013. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neofor-mans infection. MBio 4: e00265-13.
175. Taborda CP, Casadevall A. 2001. Immunoglobulin M efficacy against Cryptococcus neoformans: Mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166: 2100-2107.
176. Taborda CP, Rivera J, Zaragoza O, Casadevall A. 2003. More is not necessarily better: Prozone-like effects in passive immunization with IgG. J Immunol 170: 3621-3630.
177. Tachado SD, Zhang J, Zhu J, Patel N, Cushion M, Koziel H. 2007. Pneumocystis-mediated IL-8 release by macro-phages requires coexpression of mannose receptors and TLR2. JLeukoc Biol 81: 205-211.
178. Takagi H, Fukaya T, Eizumi K, Sato Y, Sato K, Shibazaki A, Otsuka H, Hijikata A, Watanabe T, Ohara O, et al. 2011. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35: 958-971.
179. Taylor PR, Gordon S, Martinez-Pomares L. 2005. The man-nose receptor: Linking homeostasis and immunity through sugar recognition. TrendsImmunol 26:104-110.
180. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, et al. 2007. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat Immunol 8: 31-38.
181. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, Norelli F, Bellucci C, Polonelli L, Costantino P, et al. 2005. Anovelglyco-conjugatevaccineagainstfungal pathogens. JExpMed 202: 597-606.
182. Torosantucci A, Chiani P, Bromuro C, De Bernardis F, Palma AS, Liu Y, Mignogna G, Maras B, Colone M, Stringaro A, et al. 2009. Protection by anti-β-glucan antibodies is associated with restricted β1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE 4: e5392.
183. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 164: 2021-2027.
184. Tsai HY, Yu HH, Chien YH, Chu KH, Lau YL, Lee JH, Wang LC, Chiang BL, Yang YH. 2012. X-linkedhyper-IgM syndrome with CD40LG mutation: Two case reports and literature review in Taiwanese patients. JMicrobiol Immunol Infect doi: 10.1016/j.jmii.2012.07.004.
185. Tsoni SV, Brown GD. 2008. β-Glucans and Dectin-1. Ann NY Acad Sci 1143: 45-60.
186. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, van den Berg WB, Williams DL, van der Meer JW, Joosten LA, et al. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5: 329-340.
187. Vautier S, MacCallum DM, Brown GD. 2012. C-type lectin receptors and cytokines in fungal immunity. Cytokine 58: 89-99.
188. Vinh DC, Schwartz B, Hsu AP, Miranda DJ, Valdez PA, Fink D, Lau KP, Long-Priel D, Kuhns DB, Uzel G, et al. 2011. Interleukin-12 receptor β1 deficiency predisposing to disseminated coccidioidomycosis. Clin Infect Dis 52: e99-e102.
189. Voelz K, Lammas DA, May RC. 2009. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun 77: 3450-3457.
190. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
191. Wahab JA, Hanifah MJ, Choo KE. 1995. Bruton's agamma-globulinaemia in a child presenting with cryptococcal empyema thoracis and periauricular pyogenic abscess. Singapore Med J36: 686-689.
192. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. 2004. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38: 1261-1265.
193. Wang H, LeBert V, Hung CY, Galles K, Saijo S, Lin X, Cole GT, Klein BS, Wuthrich M. 2014. C-type lectin receptors differentially induce Th17 cells and vaccine immunity to the endemic mycosis ofNorth America. JImmunol 192: 1107-1119.
194. Weiss G, Bogdan C, Hentze MW. 1997. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 158: 420-425.
195. Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo YL, Manzanero S, Cob-bold C, et al. 2008. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 180: 7404-7413.
196. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C. 2009. Requisite role for the Dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. JImmunol 182: 4938-4946.
197. Wheeler RT, Kombe D, Agarwala SD, Fink GR. 2008. Dynamic, morphotype-specific Candida albicans fS-glucan exposure during infection and drug treatment. PLoS Pathog 4: e1000227.
198. Willment JA, Brown GD. 2008. C-type lectin receptors in antifungal immunity. Trends Microbiol 16: 27-32.
199. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. 2003. The X-linked hyper-IgM syndrome: Clinical and immunologic features of 79 patients. Medicine (Baltimore) 82: 373-384.
200. Winters MS, Chan Q, Caruso JA, Deepe GS Jr. 2010. Metal-lomic analysis ofmacrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. J Infect Dis 202: 1136-1145.
201. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. 2011. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS ONE 6: e17204.
202. Wuthrich M, Filutowicz HI, Warner T, Deepe GS Jr, Klein BS. 2003. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: Implications for vaccine development in immune-deficient hosts. J Exp Med 197: 1405-1416.
203. Wuthrich M, Fisette PL, Filutowicz HI, Klein BS. 2006. Differential requirements of T cell subsets for CD40 costi-mulation in immunity to Blastomyces dermatitidis. JImmunol 176: 5538-5547.
204. Wuthrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J, Galles K, Filutowicz H, Warner T, Evans M, et al. 2011. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 121: 554-568.
205. Wuthrich M, Deepe GS Jr, Klein B. 2012a. Adaptive immunity to fungi. Annu Rev Immunol 30: 115-148.
206. Wuthrich M, Ersland K, Sullivan T, Galles K, Klein B. 2012b. Fungi subvert vaccine T-cell priming at the respiratory mucosa by inducing MMP2 and retarding CCL7-medi-ated influx of inflammatory monocytes. Immunity 36: 680-692.
207. Xin H, Cutler JE. 2011. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol 18: 1656-1667.
208. Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishi-kawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mi-kami Y, et al. 2009. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci 106: 1897-1902.
209. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695-2706.
210. Zelante T, Iannitti RG, De Luca A, Arroyo J, Blanco N, Servillo G, Sanglard D, Reichard U, Palmer GE, Latge JP, et al. 2012. Sensing of mammalian IL-17A regulates fungal adaptation and virulence. Nat Commun 3: 683.
211. Zerbe CS, Holland SM. 2005. Disseminated histoplasmosis in persons with interferon-g receptor 1deficiency. Clin Infect Dis 41: e38-e41.
212. Zhang J, Zhu J, Imrich A, Cushion M, Kinane TB, Koziel H. 2004. Pneumocystis activates human alveolar macro-phage NF-kB signaling through mannose receptors. Infect Immun 72: 3147-3160.
213. Zheng M, Ramsay AJ, Robichaux MB, Norris KA, Kliment C, Crowe C, Rapaka RR, Steele C, McAllister F, Shellito JE, et al. 2005. CD4+ T cell-independent DNAvaccina-tion against opportunistic infections. J Clin Invest 115: 3536-3544.
214. Zhu LL, Zhao XQ, Jiang C, You Y, Chen XP, Jiang YY, Jia XM, Lin X. 2013. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity.
215. Zuniga LA, Jain R, Haines C, Cua DJ. 2013. Th17 cell development: From the cradle to the grave. Immunol Rev 252: 78-88.